IMHO, this sector is very much out of favor. For example, when you look at other companies like Solazyme (SZYM), Amyris (AMRS), Codexis, (CDXS) and KiOR (KIOR), these all appear to have had a major pull back when looking at the 52 week high for each. In some cases like AMRS, the pull has been brutal. Regardless I am comfortable with Gevo and feel they are headed in the right direction and have many good partnerships that will help them succeed.
I personally do not believe that “something is fishy” going on with management. They clearly communicated earlier this year they needed to raise capital and smartly did so while the opportunity to do so was good for them. The SEC I can’t imagine would investigate anything in my point of view as “GEVO management” hasn’t done anything to warrant it, again from my perspective.
In short, I view Gevo’s chances as “above average” compared to other companies in the same market sector. I believe they have the best chances of succeeding and thus I remain patient and confident.
Thank you
Market Data 
Markets 
AI
